과제정보
This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIT) (Nos. 2020R1A2C1012007 and RS-2022-00166271), the Catholic Medical Center Research Foundation in the program year 2021, the Research Supporting Program of the Korean Gastric Cancer Association (Nos. KGCA2022IC2 and KGCA2022IC3), and the Korean Society of Endo-Laparoscopic & Robotic Surgery for 2022 (No. KSERS-22-04). The study sponsors were not involved in the study design, analysis, data interpretation, report writing, or the decision to submit the study results for publication.
참고문헌
- Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS, Seo HG. Prediction of cancer incidence and mortality in Korea, 2022. Cancer Res Treat 2022;54:345-351. https://doi.org/10.4143/crt.2022.179
- Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-led nationwide survey on surgically treated gastric cancers in 2019. J Gastric Cancer 2021;21:221-235. https://doi.org/10.5230/jgc.2021.21.e27
- Park SH, Kang MJ, Yun EH, Jung KW. Epidemiology of gastric cancer in Korea: trends in incidence and survival based on Korea Central Cancer Registry Data (1999-2019). J Gastric Cancer 2022;22:160-168. https://doi.org/10.5230/jgc.2022.22.e21
- Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2016;14:1286-1312. https://doi.org/10.6004/jnccn.2016.0137
- Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 2006;32:661-665. https://doi.org/10.1016/j.ejso.2006.03.007
- Kodera Y, Fujitani K, Fukushima N, Ito S, Muro K, Ohashi N, et al. Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese Gastric Cancer treatment guidelines. Gastric Cancer 2014;17:206-212. https://doi.org/10.1007/s10120-013-0299-x
- Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet 2016;388:2654-2664. https://doi.org/10.1016/S0140-6736(16)30354-3
- Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 2014;134:622-628. https://doi.org/10.1002/ijc.28373
- Mir TA, Malik AA, Wani MA, Rasool Z, ul Bari S. Gastric carcinoma-a new biomarker peritoneal fluid lavage cytology. Indian J Surg 2023;85:76-82.
- Schena CA, Laterza V, De Sio D, Quero G, Fiorillo C, Gunawardena G, et al. The role of staging laparoscopy for gastric cancer patients: current evidence and future perspectives. Cancers (Basel) 2023;15:3425.
- Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999;72:60-64. https://doi.org/10.1002/(SICI)1096-9098(199910)72:2<60::AID-JSO3>3.0.CO;2-1
- La Torre M, Rossi Del Monte S, Ferri M, Cosenza G, Mercantini P, Ziparo V. Peritoneal washing cytology in gastric cancer. How, when and who will get a benefit? A review. Minerva Gastroenterol Dietol 2011;57:43-51.
- Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean Practice Guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 2023;23:3-106. https://doi.org/10.5230/jgc.2023.23.e11
- Japanese Gastric Cancer Association. Japanese Gastric Cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021;24:1-21. https://doi.org/10.1007/s10120-020-01042-y
- Information Committee of Korean Gastric Cancer Association. Korean Gastric Cancer Association nationwide survey on gastric cancer in 2014. J Gastric Cancer 2016;16:131-140. https://doi.org/10.5230/jgc.2016.16.3.131
- Kurokawa Y, Doki Y, Mizusawa J, Yoshikawa T, Yamada T, Kimura Y, et al. Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001). Br J Surg 2022;110:50-56. https://doi.org/10.1093/bjs/znac373
- Garg PK, Jakhetiya A, Turaga KK, Kumar R, Brandl A, Rau B. Lack of oncological benefit from bursectomy in radical gastrectomy: a systematic review. Visc Med 2021;37:511-520. https://doi.org/10.1159/000517654
- Endo S, Nishikawa K, Fujitani K, Matsuyama J, Ikenaga M, Yamada T, et al. Is D2 lymphadenectomy essential for cytology-positive gastric cancer? a retrospective analysis. Anticancer Res 2019;39:6209-6216. https://doi.org/10.21873/anticanres.13829
- Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242. https://doi.org/10.1046/j.1365-2168.2000.01360.x
- Kang D, Kim IH. Molecular mechanisms and potential rationale of immunotherapy in peritoneal metastasis of advanced gastric cancer. Biomedicines 2022;10:1376.
- To EM, Chan WY, Chow C, Ng EK, Chung SC. Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts. Diagn Mol Pathol 2003;12:88-95. https://doi.org/10.1097/00019606-200306000-00004
- Wei J, Wu ND, Liu BR. Regional but fatal: intraperitoneal metastasis in gastric cancer. World J Gastroenterol 2016;22:7478-7485. https://doi.org/10.3748/wjg.v22.i33.7478
- Li Q, Li B, Li Q, Wei S, He Z, Huang X, et al. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis 2018;9:854.
- Xia X, Zhang Z, Zhu C, Ni B, Wang S, Yang S, et al. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat Commun 2022;13:1017.
- Gwee YX, Chia DK, So J, Ceelen W, Yong WP, Tan P, et al. Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis. J Clin Oncol 2022;40:2830.
- Huang XZ, Pang MJ, Li JY, Chen HY, Sun JX, Song YX, et al. Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. Nat Commun 2023;14:822.
- Riihimaki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget 2016;7:52307-52316. https://doi.org/10.18632/oncotarget.10740
- Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer 2013;16:1-27. https://doi.org/10.1007/s10120-012-0163-4
- Kim SH, Lee HJ, Park JH, Choi JH, Park SH, Choe HN, et al. Proposal of a new TNM classification for gastric cancer: focusing on pN3b and cytology-positive (CY1) disease. J Gastric Cancer 2019;19:329-343. https://doi.org/10.5230/jgc.2019.19.e33
- Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 2022;33:1005-1020. https://doi.org/10.1016/j.annonc.2022.07.004
- Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2022;20:167-192. https://doi.org/10.6004/jnccn.2022.0008
- Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 2011;14:97-100. https://doi.org/10.1007/s10120-011-0040-6
- Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumours. Hoboken (NJ): John Wiley & Sons, 2017.
- Kodera Y, Ito S, Mochizuki Y, Kondo K, Koshikawa K, Suzuki N, et al. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol 2009;35:1158-1163. https://doi.org/10.1016/j.ejso.2009.03.003
- Kodera Y, Ito S, Mochizuki Y, Ohashi N, Tanaka C, Kobayashi D, et al. Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study. Gastric Cancer 2012;15:335-337. https://doi.org/10.1007/s10120-012-0156-3
- Janjigian YY, Kawazoe A, Yanez P, Li N, Lonardi S, Kolesnik O, et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature 2021;600:727-730. https://doi.org/10.1038/s41586-021-04161-3
- Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017;390:2461-2471. https://doi.org/10.1016/S0140-6736(17)31827-5
- Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 2021;398:27-40. https://doi.org/10.1016/S0140-6736(21)00797-2
- Japanese Gastric Cancer Association. Japanese Gastric Cancer treatment guidelines 2021 (6th edition). Gastric Cancer 2023;26:1-25. https://doi.org/10.1007/s10120-022-01331-8